Medical conditions: Certain health conditions, such as diabetes, thyroid disorders, nerve compression (radiculopathy), spinal stenosis, and liver disease (e.g., cirrhosis), can increase the risk
These effects can lead to damage to cells and tissues, further burdening the liver and other organs involved in detoxification
However, these weight loss medications are not recommended for use during pregnancy, and ideally should be stopped at least 2 months before any planned pregnancy
statt bei T2D maximal 1,8 mg/Tag eingesetzt wird, und fr Semaglutid mit 2,4 gegenber 1,0 mg/Woche bei T2D
In laboratory peptide signaling studies, DAC-linked formats are generally described as having a longer observable activity window, while non-DAC formats are discussed in relation to shorter pulse-oriented signaling behavior
Image Credit: peterschreiber.media / Shutterstock.com A recent JAMA Otolaryngology-Head & Neck Surgery study investigates the risk of incident thyroid cancer among adults diagnosed with type 2 diabetes (T2D) and being treated with either glucagon-like peptide-1 receptor agonists (GLP-1RAs) or other glucose-lowering medications
